Physician profile
Brian S Cohen
NPI 1801811096
$8,760,913.25
in general payments reported to CMS, 2019-2025
17 companies · $2.2M in 2025
The $2.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413K · 2020: $612K · 2021: $902K · 2022: $1.2M · 2023: $1.6M · 2024: $1.9M · 2025: $2.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.6M · Consulting Fee: $37K · Travel and Lodging: $1,886 · Food and Beverage: $832 · Education: $42.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,600,353.67 |
| Consulting Fee | $37,097.50 |
| Travel and Lodging | $1,886.45 |
| Food and Beverage | $832.27 |
| Education | $42.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,756,256.34 | 2019-2025 | Arthrex |
| Stryker Corporation | $2,376.66 | 2020-2025 | Mako |
| Cdc Medical LLC | $1,220.11 | 2021-2022 | |
| Depuy Synthes Sales INC. | $300.30 | 2021-2024 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $170.73 | 2024-2025 | Persona, Atlas |
| Medical Device Business Services, INC. | $149.73 | 2021 | |
| Cosa Medical, LLC | $102.74 | 2025 | |
| Ferring Pharmaceuticals INC. | $94.48 | 2024-2025 | Euflexxa |
| Wright Medical Technology, INC. | $56.73 | 2019 | |
| Vericel Corporation | $42.74 | 2023 | Maci |
| Pacira Pharmaceuticals Incorporated | $28.16 | 2024 | Zilretta, Iovera, Exparel |
| Sanara Medtech INC. | $25.88 | 2024 | Celleraterx |
| Baxter Healthcare | $25.56 | 2024 | Perclot |
| Orthofix Medical, INC. | $16.39 | 2019 | |
| Conmed Corporation | $16.13 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $15.56 | 2022 | |
| Bioventus LLC | $15.01 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.